glycocholic acid has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caliceti, P; Del Curto, MD; Gazzaniga, A; Maroni, A; Melocchi, A; Salmaso, S; Zema, L | 1 |
| Ahmed, FJ; Diwan, PV; Jain, AK; Khar, RK | 1 |
2 other study(ies) available for glycocholic acid and Alloxan Diabetes
| Article | Year |
|---|---|
In vitro and in vivo evaluation of an oral multiple-unit formulation for colonic delivery of insulin.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Animals; Area Under Curve; Blood Glucose; Buffers; Cattle; Colon; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Drug Carriers; Drug Delivery Systems; Glycocholic Acid; Hydrogen-Ion Concentration; Insulin; Male; Methylcellulose; Microscopy, Electron, Scanning; Rats; Rats, Sprague-Dawley; Sodium; Tablets; Temperature; Viscosity | 2016 |
Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier.
Topics: Adhesives; Administration, Intranasal; Animals; Area Under Curve; Blood Glucose; Cross-Linking Reagents; Diabetes Mellitus, Experimental; Epichlorohydrin; Excipients; Glycocholic Acid; Hypoglycemic Agents; Insulin; Lysophosphatidylcholines; Male; Nanoparticles; Particle Size; Rats; Rats, Wistar; Solvents; Starch | 2008 |